SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (4864)11/6/2003 11:05:17 PM
From: StockDung   of 5582
 
Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds.

1: Clin Infect Dis. 2001 Dec 1;33(11):1865-70. Epub 2001 Oct 25. Related Articles, Links

Comment in:
Clin Infect Dis. 2002 Jun 15;34(12):1657. 

Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds.

Turner RB.

Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA. rbt2n@virginia.edu

Zinc has generally been administered by the oral route in studies of prevention or treatment of the common cold. The purpose of these studies was to evaluate the effectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus infection and illness. Ninety-one volunteers, 41 treated with active medication and 50 treated with placebo, received study medication for 3 days, were inoculated with rhinovirus, and then were treated with study medication for an additional 6 days. Rhinovirus infection was documented in 37 (74%) of the 50 placebo-treated volunteers and in 32 (78%) of the 41 volunteers treated with active medication. Zinc treatment had no effect on total symptom score, rhinorrhea, nasal obstruction, or the proportion of infected volunteers who developed clinical colds. These data do not support a role for intranasal zinc gluconate for prevention or treatment of the common cold.

Publication Types:
Clinical Trial
Randomized Controlled Trial
PMID: 11692298 [PubMed - indexed for MEDLINE]

ncbi.nlm.nih.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext